Hospital statistics for antibiotics: defined versus prescribed daily dose

Infection

Volumn 42, Issue 5, 2014, Pages 869-873

  Gagliotti, C ^a   Ricchizzi, E ^a   Buttazzi, R ^a   Tumietto, F ^b   Resi, D ^c   Moro, M L ^a  

^a Agenzia Sanitaria e Sociale Regionale Emilia Romagna   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Azienda Unità Sanitaria Locale di Ravenna   (Italy)

Author keywords

Anti bacterial agents; Defined daily dose; Hospital; Prescribed daily dose

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIUM; CROSS INFECTION; CROSS-SECTIONAL STUDY; DRUG EFFECTS; HOSPITAL; HUMAN; ITALY; MICROBIOLOGY; PRESCRIPTION; PREVALENCE; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; BACTERIA; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; HOSPITALS; HUMANS; ITALY; PREVALENCE;

EID: 84918822894     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-014-0649-6     Document Type: Article

References (22)

1. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm, ECDC, 2012.
2. Meyer E, Gastmeier P, Deja M, Schwab F. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol. 2013;303:388–95.
3. Dancer SJ, Kirkpatrick P, Corcoran DS, Christison F, Farmer D, Robertson C. Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum beta-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2013;41:137–42.
4. Fournier S, Brun-Buisson C, Jarlier V. Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE). Antimicrob Resist Infect Control. 2012;1:9.
5. Dumartin C, L’Heriteau F, Pefau M, Bertrand X, Jarno P, Boussat S, et al. Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. J Antimicrob Chemother. 2010;65:2028–36.
6. Filius PM, Liem TB, van der Linden PD, Janknegt R, Natsch S, Vulto AG, et al. HA. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother. 2005;55:805–8.
7. Kuster SP, Ruef C, Ledergerber B, Hintermann A, Deplazes C, Neuber L, Weber R. Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infection. 2008;36:549–59.
8. Muller-Pebody B, Muscat M, Pelle B, Klein BM, Brandt CT, Monnet DL. Increase and change in pattern of hospital antimicrobial use, Denmark, 1997–2001. J Antimicrob Chemother. 2004;54:1122–6.
9. Ronning M, Blix HS, Strom H, Skovlund E, Andersen M, Stichele RV. Problems in collecting comparable national drug use data in Europe: the example of antibacterials. Eur J Clin Pharmacol. 2003;58:843–9.
10. Zarb P, Ansari F, Muller A, Vankerckhoven V, Davey PG, Goossens H. Drug utilization 75% (DU75%) in 17 European hospitals (2000–2005): results from the ESAC-2 Hospital Care Sub Project. Curr Clin Pharmacol. 2011;6:62–70.
11. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2013. Oslo, WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway, 2012.
12. de With K, Maier L, Steib-Bauert M, Kern P, Kern WV. Trends in antibiotic use at a university hospital: defined or prescribed daily doses? Patient days or admissions as denominator? Infection. 2006;34:91–4.
13. de With K, Bestehorn H, Steib-Bauert M, Kern WV. Comparison of defined versus recommended versus prescribed daily doses for measuring hospital antibiotic consumption. Infection. 2009;37:349–52.
14. Fitzpatrick RW, Edwards CM. Evaluation of a tool to benchmark hospital antibiotic prescribing in the United Kingdom. Pharm World Sci. 2008;30:73–8.
15. Grimmsmann T, Himmel W. Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes? Eur J Clin Pharmacol. 2011;67:847–54.
16. Haug JB, Reikvam A. WHO defined daily doses versus hospital-adjusted defined daily doses: impact on results of antibiotic use surveillance. J Antimicrob Chemother. 2013;68:2940–7.
17. Muller A, Monnet DL, Talon D, Henon T, Bertrand X. Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol. 2006;61:585–91.
18. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007;44:664–70.
19. Koristkova B, Grundmann M, Brozmanova H. Differences between prescribed daily doses and defined daily doses of antiepileptics–therapeutic drug monitoring as a marker of the quality of the treatment. Int J Clin Pharmacol Ther. 2006;44:438–42.
20. Hartz I, Sakshaug S, Furu K, Engeland A, Eggen AE, Njolstad I, et al. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption-an individual-level prescription database study. BMC Clin Pharmacol. 2007;7:14.
21. Grimmsmann T, Himmel W. Relation between defined daily doses (DDD) and prescribed daily doses: a 3-month analysis of outpatient data from a statutory health insurance company. Gesundheitswesen. 2010;72:412–8.
22. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2012, Oslo, WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway, 2011.